Bacterial interference with canonical NFκB signalling

Microbiology (United Kingdom)

Volumn 159, Issue PART 10, 2013, Pages 2001-2013

  Johannessen, Mona ^a   Askarian, Fatemeh ^a   Sangvik, Maria ^a   Sollid, Johanna E ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; PROTEIN P50; PROTEIN P52; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN CONJUGATING ENZYME E2; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3;

ANTIBIOSIS; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTEROIDES THETAIOTAOMICRON; BORDETELLA PERTUSSIS; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; CHLAMYDIA TRACHOMATIS; CITROBACTER RODENTIUM; CYTOPLASM; ENTEROCOCCUS FAECALIS; ENZYME ACTIVATION; ESCHERICHIA COLI; FRANCISELLA TULARENSIS; HELICOBACTER PYLORI; HOST CELL; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INFLAMMATION; LEGIONELLA PNEUMOPHILA; MORAXELLA CATARRHALIS; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA GALLINARUM; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

BACTERIA; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; INFLAMMATION; NF-KAPPA B; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION;

EID: 84884788369     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.069369-0     Document Type: Review

References (104)

1. Abeyta, M., Hardy, G. G. & Yother, J. (2003). Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun 71, 218-225.
2. Albiger, B., Sandgren, A., Katsuragi, H., Meyer-Hoffert, U., Beiter, K., Wartha, F., Hornef, M., Normark, S. & Normark, B. H. (2005). Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice. Cell Microbiol 7, 1603-1615.
3. Arbibe, L., Kim, D. W., Batsche, E., Pedron, T., Mateescu, B., Muchardt, C., Parsot, C. & Sansonetti, P. J. (2007). An injected bacterial effector targets chromatin access for transcription factor NFκB to alter transcription of host genes involved in immune responses. Nat Immunol 8, 47-56.
4. Ashida, H., Kim, M., Schmidt-Supprian, M., Ma, A., Ogawa, M. & Sasakawa, C. (2010). A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKγ to dampen the host NFκB-mediated inflammatory response. Nat Cell Biol 12, 66-73, 1-9.
5. Bardoel, B. W., Vos, R., Bouman, T., Aerts, P. C., Bestebroer, J., Huizinga, E. G., Brondijk, T. H., van Strijp, J. A. & de Haas, C. J. (2012). Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3. J Mol Med (Berl) 90, 1109-1120.
6. Barrow, A. D. & Trowsdale, J. (2006). You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur J Immunol 36, 1646-1653.
7. Baruch, K., Gur-Arie, L., Nadler, C., Koby, S., Yerushalmi, G., Ben-Neriah, Y., Yogev, O., Shaulian, E., Guttman, C. & other authors (2011). Metalloprotease type III effectors that specifically cleave JNK and NF-κB. EMBO J 30, 221-231.
8. Bestebroer, J., De Haas, C. J. & Van Strijp, J. A. (2010). How microorganisms avoid phagocyte attraction. FEMS Microbiol Rev 34, 395-414.
9. Biswas, A., Wilmanski, J., Forsman, H., Hrncir, T., Hao, L., Tlaskalova-Hogenova, H. & Kobayashi, K. S. (2011). Negative regulation of Toll-like receptor signaling plays an essential role in homeostasis of the intestine. Eur J Immunol 41, 182-194.
10. Burns, K., Janssens, S., Brissoni, B., Olivos, N., Beyaert, R. & Tschopp, J. (2003). Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J Exp Med 197, 263-268.
11. Carpenter, S. & O'Neill, L. A. (2007). How important are Toll-like receptors for antimicrobial responses? Cell Microbiol 9, 1891-1901.
12. Casanova, J. L., Abel, L. & Quintana-Murci, L. (2011). Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol 29, 447-491.
13. Chen, Z. J. (2005). Ubiquitin signalling in the NF-κB pathway. Nat Cell Biol 7, 758-765.
14. Chen, L. F., Mu, Y. & Greene, W. C. (2002). Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-κB. EMBO J 21, 6539-6548.
15. Cigana, C., Curcurù, L., Leone, M. R., Ieranò, T., Lorè, N. I., Bianconi, I., Silipo, A., Cozzolino, F., Lanzetta, R. & other authors (2009). Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection. PLoS ONE 4, e8439.
16. Cirl, C., Wieser, A., Yadav, M., Duerr, S., Schubert, S., Fischer, H., Stappert, D., Wantia, N., Rodriguez, N. & other authors (2008). Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 14, 399-406.
17. Collier-Hyams, L. S., Zeng, H., Sun, J., Tomlinson, A. D., Bao, Z. Q., Chen, H., Madara, J. L., Orth, K. & Neish, A. S. (2002). Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, antiapoptotic NF-κB pathway. J Immunol 169, 2846-2850.
18. Deshmukh, H. S., Hamburger, J. B., Ahn, S. H., McCafferty, D. G., Yang, S. R. & Fowler, V. G., Jr (2009). Critical role of NOD2 in regulating the immune response to Staphylococcus aureus. Infect Immun 77, 1376-1382.
19. Domon, H., Honda, T., Oda, T., Yoshie, H. & Yamazaki, K. (2008). Early and preferential induction of IL-1 receptor-associated kinase-M in THP-1 cells by LPS derived from Porphyromonas gingivalis. J Leukoc Biol 83, 672-679.
20. Fraser, J. D. & Proft, T. (2008). The bacterial superantigen and superantigen-like proteins. Immunol Rev 225, 226-243.
21. Gao, X., Wan, F., Mateo, K., Callegari, E., Wang, D., Deng, W., Puente, J., Li, F., Chaussee, M. S. & other authors (2009). Bacterial effector binding to ribosomal protein s3 subverts NF-κB function. PLoS Pathog 5, e1000708.
22. Ge, J., Xu, H., Li, T., Zhou, Y., Zhang, Z., Li, S., Liu, L. & Shao, F. (2009). A Legionella type IV effector activates the NF-κB pathway by phosphorylating the IκB family of inhibitors. Proc Natl Acad Sci U S A 106, 13725-13730.
23. Gunn, J. S. & Ernst, R. K. (2007). The structure and function of Francisella lipopolysaccharide. Ann N Y Acad Sci 1105, 202-218.
24. Hajishengallis, G., Wang, M., Liang, S., Triantafilou, M. & Triantafilou, K. (2008). Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci U S A 105, 13532-13537.
25. Han, J. & Ulevitch, R. J. (2005). Limiting inflammatory responses during activation of innate immunity. Nat Immunol 6, 1198-1205.
26. Hoebe, K., Georgel, P., Rutschmann, S., Du, X., Mudd, S., Crozat, K., Sovath, S., Shamel, L., Hartung, T. & other authors (2005). CD36 is a sensor of diacylglycerides. Nature 433, 523-527.
27. Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K. & Akira, S. (1999). Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162, 3749-3752.
28. Huang, T. T., Kudo, N., Yoshida, M. & Miyamoto, S. (2000). A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes. Proc Natl Acad Sci U S A 97, 1014-1019.
29. Janssens, S., Burns, K., Tschopp, J. & Beyaert, R. (2002). Regulation of interleukin-1-and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88. Curr Biol 12, 467-471.
30. Jeong, E. & Lee, J. Y. (2011). Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J 52, 379-392.
31. Jiang, X. & Chen, Z. J. (2012). The role of ubiquitylation in immune defence and pathogen evasion. Nat Rev Immunol 12, 35-48.
32. Kawasaki, K., Ernst, R. K. & Miller, S. I. (2004). 3-O-deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem 279, 20044-20048.
33. Kelly, D., Campbell, J. I., King, T. P., Grant, G., Jansson, E. A., Coutts, A. G., Pettersson, S. & Conway, S. (2004). Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 5, 104-112.
34. Kersse, K., Bertrand, M. J., Lamkanfi, M. & Vandenabeele, P. (2011). NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev 22, 257-276.
35. Kim, D. W., Lenzen, G., Page, A. L., Legrain, P., Sansonetti, P. J. & Parsot, C. (2005). The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc Natl Acad Sci U S A 102, 14046-14051.
36. Kissner, T. L., Moisan, L., Mann, E., Alam, S., Ruthel, G., Ulrich, R. G., Rebek, M., Rebek, J., Jr & Saikh, K. U. (2011). A small molecule that mimics the BB-loop in the Toll interleukin-1 (IL-1) receptor domain of MyD88 attenuates staphylococcal enterotoxin B-induced proinflammatory cytokine production and toxicity in mice. J Biol Chem 286, 31385-31396.
37. Kumar, H., Kawai, T. & Akira, S. (2009). Pathogen recognition in the innate immune response. Biochem J 420, 1-16.
38. Lamb, A., Yang, X. D., Tsang, Y. H., Li, J. D., Higashi, H., Hatakeyama, M., Peek, R. M., Blanke, S. R. & Chen, L. F. (2009). Helicobacter pylori CagA activates NF-κB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO Rep 10, 1242-1249.
39. Le Negrate, G., Faustin, B., Welsh, K., Loeffler, M., Krajewska, M., Hasegawa, P., Mukherjee, S., Orth, K., Krajewski, S. & other authors (2008). Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-κB, suppresses IκBα ubiquitination and modulates innate immune responses. J Immunol 180, 5045-5056.
40. Lee, M. S. & Kim, Y. J. (2007). Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76, 447-480.
41. Lee, Y. J., Choi, H. J., Kang, T. W., Kim, H. O., Chung, M. J. & Park, Y. M. (2008). CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes. J Microbiol Biotechnol 18, 1308-1316.
42. Leendertse, M., Willems, R. J., Giebelen, I. A., van den Pangaart, P. S., Wiersinga, W. J., de Vos, A. F., Florquin, S., Bonten, M. J. & van der Poll, T. (2008). TLR2-dependent MyD88 signaling contributes to early host defense in murine Enterococcus faecium peritonitis. J Immunol 180, 4865-4874.
43. Li, Q. & Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat Rev Immunol 2, 725-734.
44. Li, C., Zienkiewicz, J. & Hawiger, J. (2005). Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1β signaling pathway. J Biol Chem 280, 26152-26159.
45. Liu, M., Haenssler, E., Uehara, T., Losick, V. P., Park, J. T. & Isberg, R. R. (2012). The Legionella pneumophila EnhC protein interferes with immunostimulatory muramyl peptide production to evade innate immunity. Cell Host Microbe 12, 166-176.
46. Losick, V. P., Haenssler, E., Moy, M. Y. & Isberg, R. R. (2010). LnaB: a Legionella pneumophila activator of NF-κB. Cell Microbiol 12, 1083-1097.
47. Madan-Lala, R., Peixoto, K. V., Re, F. & Rengarajan, J. (2011). Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation. Infect Immun 79, 4828-4838.
48. March, C., Moranta, D., Regueiro, V., Llobet, E., Tomás, A., Garmendia, J. & Bengoechea, J. A. (2011). Klebsiella pneumoniae outer membrane protein A is required to prevent the activation of airway epithelial cells. J Biol Chem 286, 9956-9967.
49. Mittal, R., Peak-Chew, S. Y. & McMahon, H. T. (2006). Acetylation of MEK2 and I κB kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc Natl Acad Sci U S A 103, 18574-18579.
50. Motta, J. P., Bermúdez-Humarán, L. G., Deraison, C., Martin, L., Rolland, C., Rousset, P., Boue, J., Dietrich, G., Chapman, K. & other authors (2012). Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med 4, 158ra144.
51. Mühlen, S., Ruchaud-Sparagano, M. H. & Kenny, B. (2011). Proteasome-independent degradation of canonical NFκB complex components by the NleC protein of pathogenic Escherichia coli. J Biol Chem 286, 5100-5107.
52. Nadler, C., Baruch, K., Kobi, S., Mills, E., Haviv, G., Farago, M., Alkalay, I., Bartfeld, S., Meyer, T. F. & other authors (2010). The type III secretion effector NleE inhibits NF-kappaB activation. PLoS. Pathog 6, e10000743.
53. Nagamatsu, K., Kuwae, A., Konaka, T., Nagai, S., Yoshida, S., Eguchi, M., Watanabe, M., Mimuro, H., Koyasu, S. & Abe, A. (2009). Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN. J Exp Med 206, 3073-3088.
54. Nakayama, M., Underhill, D. M., Petersen, T. W., Li, B., Kitamura, T., Takai, T. & Aderem, A. (2007). Paired Ig-like receptors bind to bacteria and shape TLR-mediated cytokine production. J Immunol 178, 4250-4259.
55. Nanra, J. S., Buitrago, S. M., Crawford, S., Ng, J., Fink, P. S., Hawkins, J., Scully, I. L., McNeil, L. K., Aste-Amézaga, J. M. & other authors (2012). Capsular polysaccharides are an important immune evasion mechanism for Staphylococcus aureus. Hum Vaccin Immunother 9.
56. Neish, A. S., Gewirtz, A. T., Zeng, H., Young, A. N., Hobert, M. E., Karmali, V., Rao, A. S. & Madara, J. L. (2000). Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination. Science 289, 1560-1563.
57. Nestle, F. O., Di Meglio, P., Qin, J. Z. & Nickoloff, B. J. (2009). Skin immune sentinels in health and disease. Nat Rev Immunol 9, 679-691.
58. Newman, R. M., Salunkhe, P., Godzik, A. & Reed, J. C. (2006). Identification and characterization of a novel bacterial virulence factor that shares homology with mammalian Toll/interleukin-1 receptor family proteins. Infect Immun 74, 594-601.
59. Newton, K. & Dixit, V. M. (2012). Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol 4, a006049.
60. Newton, H. J., Pearson, J. S., Badea, L., Kelly, M., Lucas, M., Holloway, G., Wagstaff, K. M., Dunstone, M. A., Sloan, J. & other authors (2010). The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-κB p65. PLoS Pathog 6, e1000898.
61. Nish, S. & Medzhitov, R. (2011). Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity 34, 629-636.
62. O'Neill, L. A. & Bowie, A. G. (2007). The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat Rev Immunol 7, 353-364.
63. O'Riordan, K. & Lee, J. C. (2004). Staphylococcus aureus capsular polysaccharides. Clin Microbiol Rev 17, 218-234.
64. Oeckinghaus, A., Hayden, M. S. & Ghosh, S. (2011). Crosstalk in NFκB signaling pathways. Nat Immunol 12, 695-708.
65. Pearson, J. S., Riedmaier, P., Marchès, O., Frankel, G. & Hartland, E. L. (2011). A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation. Mol Microbiol 80, 219-230.
66. Pennini, M. E., Perkins, D. J., Salazar, A. M., Lipsky, M. & Vogel, S. N. (2013). Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice. J Immunol 190, 307-316.
67. Pham, T. H., Gao, X., Tsai, K., Olsen, R., Wan, F. & Hardwidge, P. R. (2012). Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infect Immun 80, 2133-2140.
68. Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M. & other authors (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088.
69. Radhakrishnan, G. K., Yu, Q., Harms, J. S. & Splitter, G. A. (2009). Brucella TIR domain-containing protein mimics properties of the Toll-like receptor adaptor protein TIRAP. J Biol Chem 284, 9892-9898.
70. Salcedo, S. P., Marchesini, M. I., Lelouard, H., Fugier, E., Jolly, G., Balor, S., Muller, A., Lapaque, N., Demaria, O. & other authors (2008). Brucella control of dendritic cell maturation is dependent on the TIR-containing protein Btp1. PLoS Pathog 4, e21.
71. Sanada, T., Kim, M., Mimuro, H., Suzuki, M., Ogawa, M., Oyama, A., Ashida, H., Kobayashi, T., Koyama, T. & other authors (2012). The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 483, 623-626.
72. Sengupta, D., Koblansky, A., Gaines, J., Brown, T., West, A. P., Zhang, D., Nishikawa, T., Park, S. G., Roop, R. M., II & Ghosh, S. (2010). Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL. J Immunol 184, 956-964.
73. Shames, S. R., Bhavsar, A. P., Croxen, M. A., Law, R. J., Mak, S. H., Deng, W., Li, Y., Bidshari, R., de Hoog, C. L. & other authors (2011). The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. Cell Microbiol 13, 1542-1557.
74. Slevogt, H., Zabel, S., Opitz, B., Hocke, A., Eitel, J., N'guessan, P. D., Lucka, L., Riesbeck, K., Zimmermann, W. & other authors (2008). CEACAM1 inhibits Toll-like receptor 2-triggered antibacterial responses of human pulmonary epithelial cells. Nat Immunol 9, 1270-1278.
75. Spear, A. M., Loman, N. J., Atkins, H. S. & Pallen, M. J. (2009). Microbial TIR domains: not necessarily agents of subversion? Trends Microbiol 17, 393-398.
76. Spear, A. M., Rana, R., Jenner, D. C., Flick-Smith, H. C., Oyston, P. C., Simpson, P., Matthews, S., Byrne, B. & Atkins, H. S. (2012). A TIR domain protein from Yersinia pestis interacts with mammalian IL-1/ TLR pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plague. Microbiology 158, 1593-1606.
77. Suhir, H. & Etzioni, A. (2010). The role of Toll-like receptor signaling in human immunodeficiencies. Clin Rev Allergy Immunol 38, 11-19.
78. Sun, S. C. (2012). The noncanonical NF-κB pathway. Immunol Rev 246, 125-140.
79. Sweet, C. R., Conlon, J., Golenbock, D. T., Goguen, J. & Silverman, N. (2007). YopJ targets TRAF proteins to inhibit TLR-mediated NF-κB, MAPK and IRF3 signal transduction. Cell Microbiol 9, 2700-2715.
80. Takeda, K. & Akira, S. (2004). TLR signaling pathways. Semin Immunol 16, 3-9.
81. Takeuchi, O., Hoshino, K. & Akira, S. (2000). Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165, 5392-5396.
82. Thurlow, L. R., Thomas, V. C., Fleming, S. D. & Hancock, L. E. (2009). Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion. Infect Immun 77, 5551-5557.
83. Turvey, S. E. & Hawn, T. R. (2006). Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol 120, 1-9.
84. Underhill, D. M., Ozinsky, A., Hajjar, A. M., Stevens, A., Wilson, C. B., Bassetti, M. & Aderem, A. (1999). The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811-815.
85. van der Windt, G. J., Blok, D. C., Hoogerwerf, J. J., Lammers, A. J., de Vos, A. F., Van't Veer, C., Florquin, S., Kobayashi, K. S., Flavell, R. A. & van der Poll, T. (2012). Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia. J Infect Dis 205, 1849-1857.
86. Veldkamp, K. E. & van Strijp, J. A. (2009). Innate immune evasion by staphylococci. Adv Exp Med Biol 666, 19-31.
87. von Bernuth, H., Picard, C., Puel, A. & Casanova, J. L. (2012). Experimental and natural infections in MyD88-and IRAK-4-deficient mice and humans. Eur J Immunol 42, 3126-3135.
88. Wan, F. & Lenardo, M. J. (2010). The nuclear signaling of NF-κB: current knowledge, new insights, and future perspectives. Cell Res 20, 24-33.
89. Wan, F., Anderson, D. E., Barnitz, R. A., Snow, A., Bidere, N., Zheng, L., Hegde, V., Lam, L. T., Staudt, L. M. & other authors (2007). Ribosomal protein S3: a KH domain subunit in NF-κB complexes that mediates selective gene regulation. Cell 131, 927-939.
90. Wan, F., Weaver, A., Gao, X., Bern, M., Hardwidge, P. R. & Lenardo, M. J. (2011). IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7. Nat Immunol 12, 335-343.
91. Wanke, I., Steffen, H., Christ, C., Krismer, B., Götz, F., Peschel, A., Schaller, M. & Schittek, B. (2011). Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 131, 382-390.
92. Watters, T. M., Kenny, E. F. & O'Neill, L. A. (2007). Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol Cell Biol 85, 411-419.
93. Wolfert, M. A., Roychowdhury, A. & Boons, G. J. (2007). Modification of the structure of peptidoglycan is a strategy to avoid detection by nucleotide-binding oligomerization domain protein 1. Infect Immun 75, 706-713.
94. Xavier, R. J. & Podolsky, D. K. (2000). Microbiology. How to get along-friendly microbes in a hostile world. Science 289, 1483-1484.
95. Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J. L. & Tong, L. (2000). Structural basis for signal transduction by the Toll/ interleukin-1 receptor domains. Nature 408, 111-115.
96. Yadav, M., Zhang, J., Fischer, H., Huang, W., Lutay, N., Cirl, C., Lum, J., Miethke, T. & Svanborg, C. (2010). Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog 6, e1001120.
97. Yan, D., Wang, X., Luo, L., Cao, X. & Ge, B. (2012). Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosinebased inhibitory motifs. Nat Immunol 13, 1063-1071.
98. Ye, Z., Petrof, E. O., Boone, D., Claud, E. C. & Sun, J. (2007). Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol 171, 882-892.
99. Yen, H., Ooka, T., Iguchi, A., Hayashi, T., Sugimoto, N. & Tobe, T. (2010). NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA. PLoS Pathog 6, e1001231.
100. Yokoyama, R., Itoh, S., Kamoshida, G., Takii, T., Fujii, S., Tsuji, T. & Onozaki, K. (2012). Staphylococcal superantigen-like protein 3 binds to the Toll-like receptor 2 extracellular domain and inhibits cytokine production induced by Staphylococcus aureus, cell wall component, or lipopeptides in murine macrophages. Infect Immun 80, 2816-2825.
101. Zhang, Q., Zmasek, C. M., Cai, X. & Godzik, A. (2011a). TIR domaincontaining adaptor SARM is a late addition to the ongoing microbehost dialog. Dev Comp Immunol 35, 461-468.
102. Zhang, L., Ding, X., Cui, J., Xu, H., Chen, J., Gong, Y. N., Hu, L., Zhou, Y., Ge, J. & other authors (2011b). Cysteine methylation disrupts ubiquitin-chain sensing in NF-κB activation. Nature 481, 204-208.
103. Zhou, H., Monack, D. M., Kayagaki, N., Wertz, I., Yin, J., Wolf, B. & Dixit, V. M. (2005). Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-κ B activation. J Exp Med 202, 1327-1332.
104. Zhu, J. & Mohan, C. (2010). Toll-like receptor signaling pathways-therapeutic opportunities. Mediators Inflamm 2010, 781235.